This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 22/9/1475    most recent 01.ATV.0000029782.84357.68v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, M. Articles by Kovanen, P. T. Search for Related Content PubMed PubMed Citation Articles by Lee, M. Articles by Kovanen, P. T. Related Collections Lipid and lipoprotein metabolism Animal models of human disease Pathophysiology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1475.)
© 2002 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux

Miriam Lee; Laura Calabresi; Giulia Chiesa; Guido Franceschini; Petri T. Kovanen

From the Wihuri Research Institute (M.L., P.T.K.), Helsinki, Finland, Center E. Grossi Paoletti and Institute of Pharmacological Sciences (L.C., G.C., G.F.), University of Milan, Milan, Italy, and Faculty of Biology (M.L.), University of Havana, Vedado, Habana, Cuba.

Correspondence to Petri T. Kovanen, MD, Wihuri Research Institute, Kalliolinnatie 4, Helsinki 00140, Finland. E-mail petri.kovanen{at}wri.fi

Objective— Mast cell chymase is a chymotryptic heparin proteoglycan–bound neutral protease that exerts its activity in extracellular fluids. We studied the effect of chymase on the apolipoprotein compositions and the abilities of plasmas from apolipoprotein (apo)A-I–knockout (A-I-KO) and wild-type (C57BL/6J) mice to stimulate efflux of cellular cholesterol from mouse macrophage foam cells.

Methods and Results— The A-I-KO apolipoproteins compared with the wild-type (apoA-I, apoA-II, apoA-IV, and apoE) showed total lack of apoA-I, unaltered apoA-II, an absence of apoA-IV, and an increase of apoE. Despite these major differences, the 2 plasmas induced similar high-affinity efflux of cholesterol from the foam cells. Quantitative analysis of chymase-treated plasmas revealed (1) in A-I-KO plasma, complete loss of apoE and apoA-II, and (2) in wild-type plasma, slight reduction of apoA-I associated with complete depletion of the minor pre-ß-high density lipoprotein fraction, strong reduction of apoA-II, and complete depletion of apoA-IV and apoE. Both proteolyzed plasmas had lost the ability to induce cellular cholesterol efflux with high affinity. Addition of discoidal pre-ß-migrating reconstituted high density lipoprotein particles containing human apoA-I or apoA-II to the chymase-treated A-I-KO plasma fully restored its cholesterol efflux–inducing ability, indicating functional replacement of the proteolyzed apoE and apoA-II. Thus, chymase degraded all the nondeleted apolipoproteins of the A-I-KO plasma involved in the high-affinity efflux of cellular cholesterol.

Conclusions— This is the first indication that genetically engineered mice could be used as models for examining the hypothesis that extracellular proteases are involved in the development of atherosclerosis by inhibiting the apolipoprotein-mediated removal of macrophage cholesterol.

Key Words: apolipoprotein A-I–knockout mice • chymase • mast cells • reconstituted HDL • reverse cholesterol transport

This article has been cited by other articles:

				M. Lee-Rueckert, R. Vikstedt, J. Metso, M. Jauhiainen, and P. T. Kovanen Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase J. Lipid Res., February 1, 2008; 49(2): 358 - 368. [Abstract] [Full Text] [PDF]

				P. Libby and G.-P. Shi Mast Cells as Mediators and Modulators of Atherogenesis Circulation, May 15, 2007; 115(19): 2471 - 2473. [Full Text] [PDF]

				M. Lee-Rueckert, R. Vikstedt, J. Metso, C. Ehnholm, P. T. Kovanen, and M. Jauhiainen Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells J. Lipid Res., August 1, 2006; 47(8): 1725 - 1732. [Abstract] [Full Text] [PDF]

				F. Schiemann, T. A. Grimm, J. Hoch, R. Gross, B. Lindner, F. Petersen, S. Bulfone-Paus, and E. Brandt Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G Blood, March 15, 2006; 107(6): 2234 - 2242. [Abstract] [Full Text] [PDF]

				P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF]

				E. Favari, M. Lee, L. Calabresi, G. Franceschini, F. Zimetti, F. Bernini, and P. T. Kovanen Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein J. Biol. Chem., March 12, 2004; 279(11): 9930 - 9936. [Abstract] [Full Text] [PDF]

				M. Lee, J. Metso, M. Jauhiainen, and P. T. Kovanen Degradation of Phospholipid Transfer Protein (PLTP) and PLTP-generated Pre-beta -high Density Lipoprotein by Mast Cell Chymase Impairs High Affinity Efflux of Cholesterol from Macrophage Foam Cells J. Biol. Chem., April 4, 2003; 278(15): 13539 - 13545. [Abstract] [Full Text] [PDF]